APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Prothrombin Complex

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Selected research

Industry Growth & Trends

Global Human Prothrombin Complex Industry Growth and Trends Forecast to 2032

21 December 202591 pages

Choose your research edition.

Industry ResearchHuman Prothrombin Complex Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Prothrombin Complex Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Human Prothrombin Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Prothrombin Complex Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Prothrombin Complex Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

Read the full market overview

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

Report Scope

This report provides a structured, data-driven view of the global Human Prothrombin Complex market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Prothrombin Complex market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Prothrombin Complex market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Prothrombin Complex.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Prothrombin Complex market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Prothrombin Complex Market by Company

Takeda

CSL

Grifols

Octapharma

Hualan Biological

Meheco Xinxing Pharma

Human Prothrombin Complex Segment by Type

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Human Prothrombin Complex Segment by Application

Hemophilia B

Vitamin K Deficiency

Others

Human Prothrombin Complex Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500 IU/Vial Table 2. Major Company of 600 IU/Vial Table 3. Major Company of 1000 IU/Vial Table 4. Major Company of Others Table 5. Global Human Prothrombin Complex Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Human Prothrombin Complex Sales by Type (2021-2026) & (K Units) Table 7. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2021-2026) Table 8. Global Human Prothrombin Complex Sales by Type (2021-2026) & (US$ Million) Table 9. Global Human Prothrombin Complex Sales Market Share in Value by Type (2021-2026) Table 10. Global Human Prothrombin Complex Price by Type (2021-2026) & (M USD/Unit) Table 11. Global Human Prothrombin Complex Sales by Type (2027-2032) & (K Units) Table 12. Global Human Prothrombin Complex Sales Market Share in Volume by Type (2027-2032) Table 13. Global Human Prothrombin Complex Sales by Type (2027-2032) & (US$ Million) Table 14. Global Human Prothrombin Complex Sales Market Share in Value by Type (2027-2032) Table 15. Global Human Prothrombin Complex Price by Type (2027-2032) & (M USD/Unit) Table 16. North America Human Prothrombin Complex Sales by Type (2021-2026) & (K Units) Table 17. North America Human Prothrombin Complex Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Human Prothrombin Complex Sales by Type (2021-2026) & (K Units) Table 19. Europe Human Prothrombin Complex Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Human Prothrombin Complex Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Human Prothrombin Complex Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Human Prothrombin Complex Sales by Type (2021-2026) & (K Units) Table 23. Latin America Human Prothrombin Complex Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Human Prothrombin Complex Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Human Prothrombin Complex Sales by Type (2021-2026) & (US$ Million) Table 26. Human Prothrombin Complex Industry Trends Table 27. Human Prothrombin Complex Industry Drivers Table 28. Human Prothrombin Complex Industry Opportunities and Challenges Table 29. Human Prothrombin Complex Industry Restraints Table 30. Global Human Prothrombin Complex Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Human Prothrombin Complex Revenue Market Share by Company (2021-2026) Table 32. Global Human Prothrombin Complex Sales by Company (2021-2026) & (K Units) Table 33. Global Human Prothrombin Complex Sales Share by Company (2021-2026) Table 34. Global Human Prothrombin Complex Market Price by Company (2021-2026) & (M USD/Unit) Table 35. Global Human Prothrombin Complex Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Human Prothrombin Complex Major Company Production Sites and Headquarters Table 37. Global Human Prothrombin Complex Company, Product Type & Application Table 38. Global Human Prothrombin Complex Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Human Prothrombin Complex Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Human Prothrombin Complex Sales by Region (2021-2026) & (K Units) Table 43. Global Human Prothrombin Complex Sales Market Share in Volume by Region (2021-2026) Table 44. Global Human Prothrombin Complex Sales by Region (2021-2026) & (US$ Million) Table 45. Global Human Prothrombin Complex Sales Market Share in Value by Region (2021-2026) Table 46. Global Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026) Table 47. Global Human Prothrombin Complex Sales by Region (2027-2032) & (K Units) Table 48. Global Human Prothrombin Complex Sales Market Share in Volume by Region (2027-2032) Table 49. Global Human Prothrombin Complex Sales by Region (2027-2032) & (US$ Million) Table 50. Global Human Prothrombin Complex Sales Market Share in Value by Region (2027-2032) Table 51. Global Human Prothrombin Complex Sales (K Units), Value (US$ Million), Price (M USD/Unit) and Gross Margin (2027-2032) Table 52. Global Human Prothrombin Complex Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Human Prothrombin Complex Sales by Application (2021-2026) & (K Units) Table 54. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2021-2026) Table 55. Global Human Prothrombin Complex Sales by Application (2021-2026) & (US$ Million) Table 56. Global Human Prothrombin Complex Sales Market Share in Value by Application (2021-2026) Table 57. Global Human Prothrombin Complex Price by Application (2021-2026) & (M USD/Unit) Table 58. Global Human Prothrombin Complex Sales by Application (2027-2032) & (K Units) Table 59. Global Human Prothrombin Complex Sales Market Share in Volume by Application (2027-2032) Table 60. Global Human Prothrombin Complex Sales by Application (2027-2032) & (US$ Million) Table 61. Global Human Prothrombin Complex Sales Market Share in Value by Application (2027-2032) Table 62. Global Human Prothrombin Complex Price by Application (2027-2032) & (M USD/Unit) Table 63. North America Human Prothrombin Complex Sales by Application (2021-2026) & (K Units) Table 64. North America Human Prothrombin Complex Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Human Prothrombin Complex Sales by Application (2021-2026) & (K Units) Table 66. Europe Human Prothrombin Complex Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Human Prothrombin Complex Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Human Prothrombin Complex Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Human Prothrombin Complex Sales by Application (2021-2026) & (K Units) Table 70. Latin America Human Prothrombin Complex Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Human Prothrombin Complex Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Human Prothrombin Complex Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026) Table 76. Takeda Human Prothrombin Complex Product Portfolio Table 77. Takeda Recent Development Table 78. CSL Company Information Table 79. CSL Business Overview Table 80. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026) Table 81. CSL Human Prothrombin Complex Product Portfolio Table 82. CSL Recent Development Table 83. Grifols Company Information Table 84. Grifols Business Overview Table 85. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026) Table 86. Grifols Human Prothrombin Complex Product Portfolio Table 87. Grifols Recent Development Table 88. Octapharma Company Information Table 89. Octapharma Business Overview Table 90. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026) Table 91. Octapharma Human Prothrombin Complex Product Portfolio Table 92. Octapharma Recent Development Table 93. Hualan Biological Company Information Table 94. Hualan Biological Business Overview Table 95. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026) Table 96. Hualan Biological Human Prothrombin Complex Product Portfolio Table 97. Hualan Biological Recent Development Table 98. Meheco Xinxing Pharma Company Information Table 99. Meheco Xinxing Pharma Business Overview Table 100. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026) Table 101. Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio Table 102. Meheco Xinxing Pharma Recent Development Table 103. North America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 105. North America Human Prothrombin Complex Sales Market Share by Country (2021-2026) Table 106. North America Human Prothrombin Complex Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Human Prothrombin Complex Sales Market Share Forecast by Country (2027-2032) Table 108. North America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Human Prothrombin Complex Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Human Prothrombin Complex Market Share by Country (2021-2026) Table 111. North America Human Prothrombin Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Human Prothrombin Complex Market Share Forecast by Country (2027-2032) Table 113. Europe Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 115. Europe Human Prothrombin Complex Sales Market Share by Country (2021-2026) Table 116. Europe Human Prothrombin Complex Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Human Prothrombin Complex Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Human Prothrombin Complex Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Human Prothrombin Complex Market Share by Country (2021-2026) Table 121. Europe Human Prothrombin Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Human Prothrombin Complex Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Human Prothrombin Complex Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Human Prothrombin Complex Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Human Prothrombin Complex Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Human Prothrombin Complex Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Human Prothrombin Complex Market Share by Country (2021-2026) Table 131. Asia-Pacific Human Prothrombin Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Human Prothrombin Complex Market Share Forecast by Country (2027-2032) Table 133. Latin America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 135. Latin America Human Prothrombin Complex Sales Market Share by Country (2021-2026) Table 136. Latin America Human Prothrombin Complex Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Human Prothrombin Complex Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Human Prothrombin Complex Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Human Prothrombin Complex Market Share by Country (2021-2026) Table 141. Latin America Human Prothrombin Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Human Prothrombin Complex Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Human Prothrombin Complex Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Human Prothrombin Complex Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Human Prothrombin Complex Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Human Prothrombin Complex Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Human Prothrombin Complex Market Share by Country (2021-2026) Table 151. Middle East and Africa Human Prothrombin Complex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Human Prothrombin Complex Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Human Prothrombin Complex Distributors List Table 156. Human Prothrombin Complex Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Human Prothrombin Complex Image Figure 2. Global Human Prothrombin Complex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Prothrombin Complex Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Prothrombin Complex Sales (2021-2032) & (K Units) Figure 5. 500 IU/Vial Image Figure 6. Global 500 IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 600 IU/Vial Image Figure 8. Global 600 IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. 1000 IU/Vial Image Figure 10. Global 1000 IU/Vial Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Human Prothrombin Complex Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Human Prothrombin Complex Market Share by Type 2025 VS 2032 Figure 15. North America Human Prothrombin Complex Sales Market Share in Volume by Type in 2025 Figure 16. North America Human Prothrombin Complex Sales Market Share in Value by Type in 2025 Figure 17. Europe Human Prothrombin Complex Sales Market Share in Volume by Type in 2025 Figure 18. Europe Human Prothrombin Complex Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Human Prothrombin Complex Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Human Prothrombin Complex Sales Market Share in Value by Type in 2025 Figure 21. Latin America Human Prothrombin Complex Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Human Prothrombin Complex Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Human Prothrombin Complex Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Human Prothrombin Complex Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hemophilia B Image Figure 28. Global Hemophilia B Sales YoY Growth (2021-2032) & (K Units) Figure 29. Vitamin K Deficiency Image Figure 30. Global Vitamin K Deficiency Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Human Prothrombin Complex Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Human Prothrombin Complex Market Share by Application 2025 VS 2032 Figure 35. North America Human Prothrombin Complex Sales Market Share in Volume by Application in 2025 Figure 36. North America Human Prothrombin Complex Sales Market Share in Value by Application in 2025 Figure 37. Europe Human Prothrombin Complex Sales Market Share in Volume by Application in 2025 Figure 38. Europe Human Prothrombin Complex Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Human Prothrombin Complex Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Human Prothrombin Complex Sales Market Share in Value by Application in 2025 Figure 41. Latin America Human Prothrombin Complex Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Human Prothrombin Complex Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Human Prothrombin Complex Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Human Prothrombin Complex Sales Market Share in Value by Application in 2025 Figure 45. North America Human Prothrombin Complex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Human Prothrombin Complex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Human Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Human Prothrombin Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Prothrombin Complex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Human Prothrombin Complex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Human Prothrombin Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Prothrombin Complex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Human Prothrombin Complex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Human Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Human Prothrombin Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Prothrombin Complex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Human Prothrombin Complex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Human Prothrombin Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Prothrombin Complex Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Human Prothrombin Complex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Human Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Human Prothrombin Complex Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Prothrombin Complex Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Human Prothrombin Complex Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 500 IU/Vial
  • 600 IU/Vial
  • 1000 IU/Vial
  • Others
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Hualan Biological
  • Meheco Xinxing Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Prothrombin Complex Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Prothrombin Complex Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Prothrombin Complex Market by Type
  6. 1.3.1 500 IU/Vial
  7. 1.3.2 600 IU/Vial
  8. 1.3.3 1000 IU/Vial
  9. 1.3.4 Others
  10. 1.4 Global Human Prothrombin Complex Market Size by Type
  11. 1.4.1 Global Human Prothrombin Complex Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Human Prothrombin Complex Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Human Prothrombin Complex Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Human Prothrombin Complex Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Human Prothrombin Complex Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Prothrombin Complex Industry Trends
  2. 2.2 Human Prothrombin Complex Industry Drivers
  3. 2.3 Human Prothrombin Complex Industry Opportunities and Challenges
  4. 2.4 Human Prothrombin Complex Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Prothrombin Complex Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Prothrombin Complex Sales (2021-2026)
  3. 3.3 Global Top Players by Human Prothrombin Complex Price (2021-2026)
  4. 3.4 Global Human Prothrombin Complex Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Prothrombin Complex Major Company Production Sites & Headquarters
  6. 3.6 Global Human Prothrombin Complex Company, Product Type & Application
  7. 3.7 Global Human Prothrombin Complex Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Prothrombin Complex Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Prothrombin Complex Tier 1, Tier 2, and Tier 3
4 Human Prothrombin Complex Regional Status and Outlook
  1. 4.1 Global Human Prothrombin Complex Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Prothrombin Complex Historic Market Size by Region
  3. 4.2.1 Global Human Prothrombin Complex Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Prothrombin Complex Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Prothrombin Complex Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Prothrombin Complex Forecasted Market Size by Region
  7. 4.3.1 Global Human Prothrombin Complex Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Prothrombin Complex Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Prothrombin Complex Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Prothrombin Complex by Application
  1. 5.1 Human Prothrombin Complex Market by Application
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Vitamin K Deficiency
  4. 5.1.3 Others
  5. 5.2 Global Human Prothrombin Complex Market Size by Application
  6. 5.2.1 Global Human Prothrombin Complex Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Prothrombin Complex Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Prothrombin Complex Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Prothrombin Complex Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Prothrombin Complex Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Prothrombin Complex Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Prothrombin Complex Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Prothrombin Complex Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Human Prothrombin Complex Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Human Prothrombin Complex Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grifols Human Prothrombin Complex Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Human Prothrombin Complex Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Hualan Biological
  26. 6.5.1 Hualan Biological Company Information
  27. 6.5.2 Hualan Biological Business Overview
  28. 6.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
  30. 6.5.5 Hualan Biological Recent Developments
  31. 6.6 Meheco Xinxing Pharma
  32. 6.6.1 Meheco Xinxing Pharma Company Information
  33. 6.6.2 Meheco Xinxing Pharma Business Overview
  34. 6.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
  36. 6.6.5 Meheco Xinxing Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Human Prothrombin Complex Sales by Country
  2. 7.1.1 North America Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Prothrombin Complex Sales by Country (2021-2026)
  4. 7.1.3 North America Human Prothrombin Complex Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Prothrombin Complex Market Size by Country
  6. 7.2.1 North America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Prothrombin Complex Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Prothrombin Complex Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Prothrombin Complex Sales by Country
  2. 8.1.1 Europe Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Prothrombin Complex Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Prothrombin Complex Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Prothrombin Complex Market Size by Country
  6. 8.2.1 Europe Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Prothrombin Complex Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Prothrombin Complex Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Prothrombin Complex Sales by Country
  2. 9.1.1 Asia-Pacific Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Prothrombin Complex Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Prothrombin Complex Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Prothrombin Complex Market Size by Country
  6. 9.2.1 Asia-Pacific Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Prothrombin Complex Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Prothrombin Complex Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Prothrombin Complex Sales by Country
  2. 10.1.1 South America Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Prothrombin Complex Sales by Country (2021-2026)
  4. 10.1.3 South America Human Prothrombin Complex Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Prothrombin Complex Market Size by Country
  6. 10.2.1 South America Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Prothrombin Complex Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Prothrombin Complex Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Prothrombin Complex Sales by Country
  2. 11.1.1 Middle East and Africa Human Prothrombin Complex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Prothrombin Complex Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Prothrombin Complex Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Prothrombin Complex Market Size by Country
  6. 11.2.1 Middle East and Africa Human Prothrombin Complex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Prothrombin Complex Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Prothrombin Complex Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Prothrombin Complex Value Chain Analysis
  2. 12.1.1 Human Prothrombin Complex Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Prothrombin Complex Production Mode & Process
  7. 12.2 Human Prothrombin Complex Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Prothrombin Complex Distributors
  10. 12.2.3 Human Prothrombin Complex Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst